New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Alcon Inc.
ALC
Shape
US Flag

NYSE

46B

Medical - Instruments & Supplies

Next Earning date - 12 Nov 2024

46B

Medical - Instruments & Supplies

Next Earning date - 12 Nov 2024

94.25USD
Shape-0.14 ( -0.15%)
favorite-chart

Relative Strenght

53
favorite-chart

Volume Buzz

-44%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

7%

Quote Panel

Shape
Updated October 26, 2024
1W -0.11 % 1M -5.41 % 3M 1.06 % 1Y 35.05 %

Key Metrics

Shape
  • Market Cap

    46.49B


  • Shares Outstanding

    493.30M


  • Share in Float

    486.75M


  • Dividende

    0.27


  • Earning Date

    12 Nov 2024


  • Price Target

    94.25


  • Average Volume

    725773


  • Beta

    0.717


  • Range

    69.53-101.1


  • Industry

    Medical - Instruments & Supplies


  • Website

    https://www.alcon.com


  • Sector

    Healthcare


Fundamentals

Shape

32.84x

P/E Ratio

4.76x

P/S Ratio

2.23x

P/B Ratio

0.2

Debt/Equity

11.3%

Net Margin

$2.2

EPS

How ALC compares to sector?

P/E Ratio

Relative Strength

Shape

ALC

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$11B

Shape324%

2025-Revenue

$2.36

Shape425%

2025-EPS

$2B

Shape234%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

RBC Capital

upgrade

Previous: Not converted

2024-09-10

Now: Outperform

Oppenheimer

upgrade

Previous: Not converted

2024-05-15

Now: Outperform

Goldman Sachs

initialise

Previous: Not converted

2024-04-10

Now: Buy

Bernstein

initialise

Previous: Not converted

2024-01-23

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-7%

0.5
vs 0.54

Q4.22

arrow
arrow

-25%

0.42
vs 0.56

Q1.23

arrow
arrow

+3%

0.7
vs 0.68

Q2.23

arrow
arrow

+10%

0.69
vs 0.63

Q3.23

arrow
arrow

+32%

0.66
vs 0.5

Q4.23

arrow
arrow

+64%

0.69
vs 0.42

Q1.24

arrow
arrow

+11%

0.78
vs 0.7

Q2.24

arrow
arrow

+7%

0.74
vs 0.69

Q3.24

arrow
arrow

+13%

0.75
vs 0.66

Q4.24

arrow
arrow

+12%

0.77
vs 0.69

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+2%

2.1B  vs 2.1B

Q4.22

arrow
arrow

+1%

2.2B  vs 2.1B

Q1.23

arrow
arrow

+7%

2.4B  vs 2.2B

Q2.23

arrow
arrow

+9%

2.4B  vs 2.2B

Q3.23

arrow
arrow

+9%

2.3B  vs 2.1B

Q4.23

arrow
arrow

+14%

2.5B  vs 2.2B

Q1.24

arrow
arrow

+5%

2.5B  vs 2.4B

Q2.24

arrow
arrow

+4%

2.5B  vs 2.4B

Q3.24

arrow
arrow

+7%

2.5B  vs 2.3B

Q4.24

arrow
arrow

+0%

2.5B  vs 2.5B

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+1%

0.01
vs 0.01

Q4.22

arrow
arrow

0%

-0.00
vs 0.01

Q1.23

arrow
arrow

+1%

0.01
vs -0.00

Q2.23

arrow
arrow

+1%

0.01
vs 0.01

Q3.23

arrow
arrow

+1%

0.01
vs 0.01

Q4.23

arrow
arrow

+2%

0.02
vs 0.01

Q1.24

arrow
arrow

+1%

0.01
vs 0.02

Q2.24

arrow
arrow

+1%

0.01
vs 0.01

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

563

563
vs 612

-8%

Q4.22

arrow
arrow

589

589
vs 563

5%

Q1.23

arrow
arrow

605

605
vs 589

3%

Q2.23

arrow
arrow

599

599
vs 605

-1%

Q3.23

arrow
arrow

607

607
vs 599

1%

Q4.23

arrow
arrow

621

621
vs 607

2%

Q1.24

arrow
arrow

630

630
vs 621

1%

Q2.24

arrow
arrow

634

634
vs 630

1%

Earnings Growth

Latest News